Aralez To Announce First Quarter 2016 Results On May 10, 2016
Aralez To Announce First Quarter 2016 Results On May 10, 2016
Canada NewsWire
MILTON, Ontario, April 28, 2016
-Executive Management to Host Conference Call on May 10, 2016 at 8:30 a.m. ET-
MILTON, Ontario, April 28, 2016 /CNW/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ)(TSX: ARZ), today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET to discuss the financial results and recent highlights.
Audio Webcast/ Conference Call Details
Date: Tuesday, May 10, 2016
Time: 8:30 a.m. ET
Dial-in (U.S.): 877-407-8037
Dial-in (International): 201-689-8037
A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for two weeks.
About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while focusing on creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Ontario, Canada, its US Headquarters is planned to be in Princeton, NJ and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be found at www.aralez.com.
Aralez Pharmaceuticals US Inc. Contact
Nichol L. Ochsner
Executive Director, Investor Relations & Corporate Communications
732-754-2545
nochsner@aralez.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aralez-to-announce-first-quarter-2016-results-on-may-10-2016-300258956.html
SOURCE Aralez Pharmaceuticals Inc.
Copyright CNW Group 2016